
|Articles|September 1, 2003
The Head of its Class
Author(s)Jennifer Clark
San Francisco - Oral terbinafine (Lamisil) is the most cost-effective treatment for toenail onychomycosis as compared to other available agents, according to the results of an economic evaluation.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











